15612 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

Place: CDC, Building 19, Rooms 

256/257, 1600 Clifton Road, NE., 

Atlanta, Georgia 30333. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 50 

people. The public is welcome to 

participate during the public comment 

period, which is tentatively scheduled 

from 5:30 to 5:45 p.m. This meeting is 

also available by teleconference, please 

dial (866) 763–0273 and enter code 

6158968. 

Purpose: The Subcommittee will 

provide advice to the CDC Director 

through the ACD on strategic and other 

health disparities and health equity 

issues and provide guidance on 

opportunities for CDC. 

Matters To Be Discussed: The Health 

Disparities Subcommittee members will 

discuss health equity in injury 

prevention, progress toward the ACD, 

CDC-approved Health Disparities 

Subcommittee recommendations, and 

updates on selected priorities of the 

Health Disparities Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

Web links: 

Windows Media: http:// 

wm.onlinevideoservice.com/CDC1. 

Flash: http:// 

www.onlinevideoservice.com/clients/ 

CDC/?mount=CDC3. 

If you are unable to connect using the 

link, copy and paste the link into your 

web browser. 

Number for Technical Support: 404– 

639–3737. 

Contact Person For More Information: 

Leandris Liburd, Ph.D., M.P.H., M.A., 

Designated Federal Officer, Health 

Disparities Subcommittee, Advisory 

Committee to the Director, CDC, 1600 

Clifton Road NE., M/S K–77, Atlanta, 

Georgia 30333, Telephone 770–488– 

8343, Email: LEL1@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2015–06645 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0797] 

The Food and Drug Administration 

Food Safety Modernization Act: Focus 

on Implementation Strategy for 

Prevention-Oriented Food Safety 

Standards; Public Meeting and 

Establishment of Docket 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting and 

establishment of docket. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing the establishment of a 

docket to obtain comments that will 

inform our development of FDA Food 

Safety Modernization Act (FSMA) 

implementation work plans. FDA is also 

announcing a public meeting entitled 

‘‘FDA Food Safety Modernization Act: 

Focus on Implementation Strategy for 

Prevention-Oriented Food Safety 

Standards.’’ At the public meeting, we 

will share our current thinking on our 

operational strategy for implementation 

work plans. We will also provide 

interested persons an opportunity to 

provide input on this operational 

strategy and the risk-based industry 

oversight framework that is at the core 

of FSMA. 

DATES: See section III, ‘‘How to 

Participate in the Public Meeting’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document for dates and times of the 

public meeting, closing dates for 

advance registration, requesting special 

accommodations due to disability, and 

information on deadlines for submitting 

either electronic or written comments to 

FDA’s Division of Dockets Management. 

ADDRESSES: See section III, ‘‘How to 

Participate in the Public Meeting’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: For 

questions about registering for the 

meeting or to register by phone: 

Courtney Treece, Planning Professionals 

Ltd., 1210 West McDermott Dr., suite 

111, Allen, TX 75013, 704–258–4983, 

FAX: 469–854–6992, email: 

ctreece@planningprofessionals.com. 

For general questions about the 

meeting or for special accommodations 

due to a disability: Juanita Yates, Center 

for Food Safety and Applied Nutrition 

(HFS–009), Food and Drug 

Administration, 5100 Paint Branch 

Pkwy., College Park, MD 20740, 240– 

402–1731, email: 

Juanita.yates@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The FDA Food Safety Modernization 

Act (FSMA) (Pub. L. 111–353), signed 

into law by President Obama on January 

4, 2011, enables FDA to better protect 

public health by helping to ensure the 

safety and security of the food supply. 

FSMA amends the Federal Food, Drug, 

and Cosmetic Act to establish the 

foundation of a modernized, preventionbased food safety system. Among other 

things, FSMA requires FDA to issue 

regulations regarding produce safety, 

preventive controls for foods for 

humans and animals, intentional 

adulteration, the foreign supplier 

verification program (FSVP), and the 

FDA third-party accreditation program. 

While FSMA reinforces industry’s 

primary role and responsibility for food 

safety, it also builds on and strengthens 

FDA’s oversight role in establishing 

food safety standards, fostering 

compliance with those standards 

through guidance and technical 

assistance, and enforcing the standards 

to protect public health when problems 

occur. In fact, more so than ever before, 

we are called upon by FSMA to play a 

central leadership and operational role 

in the future global food safety system. 

Meeting this challenge—and 

successfully implementing FSMA’s new 

prevention-oriented, systems approach 

to food safety—necessitates a new 

strategy for how we perform our food 

safety role and meet our new 

responsibilities. 

On May 2, 2014, we released our 

‘‘Operational Strategy for Implementing 

the FDA Food Safety Modernization Act 

(FSMA),’’ available electronically at 

http://www.fda.gov/Food/ 

GuidanceRegulation/FSMA/ 

ucm395105.htm, to guide the next phase 

of FSMA implementation. The 

operational strategy broadly outlines our 

approach to food safety and the 

operational strategy for our food safety 

program and implementation of FSMA 

after the rulemaking is complete. Within 

the ‘‘Operational Strategy for 

Implementing FSMA,’’ there is an 

appendix that outlines guiding 

principles for how the operational 

strategy can be implemented with 

respect to food and feed facilities, 

produce safety standards, and import 

oversight. The guiding principles 

include the following: Expanding 

inspection and surveillance; 

administering new administrative 

enforcement tools; developing guidance, 

education, and technical assistance 

tools; and building a preventionoriented import system. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 15613 

The public meeting is an opportunity 

for interested persons to share views 

concerning how FDA should address 

the operational aspects of FSMA 

implementation as suggested by the 

guiding principles. However, the 

guiding principles do not lay out an 

exhaustive list of operational issues to 

be considered. Therefore, interested 

persons will have an opportunity at the 

public meeting to share views and 

suggest new ideas on a range of 

operational issues that FDA might 

consider in our FSMA implementation 

approach. Furthermore, the public 

meeting is an opportunity for FDA to 

share our current thinking on our 

implementation plans. We encourage 

interested persons to provide feedback 

on any ideas that we present at the 

public meeting related to the 

operational aspects of FSMA 

implementation. We are also 

establishing a docket to obtain 

comments that will inform our 

development of FSMA implementation 

work plans. The agenda and other 

documents will be accessible on our 

FSMA Web site at http://www.fda.gov/ 

FSMA before the public meeting. 

II. Purpose and Format of the Public 

Meeting 

FDA is holding this public meeting on 

FSMA implementation to provide an 

update on current planning efforts and 

to receive input from the public to 

inform the development of operational 

work plans in the areas of produce 

safety, preventive controls for foods for 

humans and animals, measures to 

address intentional adulteration, FSVP, 

and the FDA third-party accreditation 

program. Please note that input received 

previously through our continued 

engagement with interested parties as 

part of the FSMA proposed rules’ 

rulemaking process will also be 

considered in the development of 

operational work plans. However, the 

Agency will not accept any new 

information or data submitted during 

the public meeting or through the 

docket to inform any rulemaking. 

FDA will provide multiple 

opportunities for individuals to actively 

express their views. At the meeting, 

following introductory presentations by 

FDA, stakeholders will have an 

opportunity to participate in their 

choice of breakout sessions on the 

topics discussed at the meeting and 

engage in an open comment and 

question and answer session. Interested 

parties may also submit electronic or 

written comments to the docket by May 

26, 2015. Breakout sessions will cover 

operational aspects of produce safety, 

preventive controls for human and 

animal food, intentional adulteration, 

FSVP, and the FDA third-party 

accreditation program, as well as 

overarching topics. We invite the public 

to provide information, share 

experiences, and raise issues on topics 

that will be addressed in the breakout 

sessions including (but limited to): 

increasing awareness/reaching the 

regulated community, potential partners 

on outreach and implementation, state 

of readiness, barriers to implementation, 

training and education for industry and 

regulators, guidance needs, promotion 

of best practices, technical assistance, 

data needs, inspection changes/ 

approaches, compliance and 

enforcement issues, and long-term 

implementation success. 

There will be an opportunity for 

stakeholders who are unable to 

participate in person to join the meeting 

via Web cast. (See section III of this 

document for more information on the 

Web cast option.) 

III. How To Participate in the Public 

Meeting 

FDA is holding the public meeting on 

April 23, 2015, from 8:30 a.m. to 5:30 

p.m. and April 24, 2015, from 8:30 a.m. 

to 12:30 p.m. Due to limited space and 

time, we encourage all persons who 

wish to attend the meeting to register in 

advance. There is no fee to register for 

the public meeting, and registration will 

be on a first-come, first-served basis. 

Onsite registration will be accepted, as 

space permits, after all preregistered 

attendees are seated. While there is not 

a formal comment session planned for 

the public meeting, it is anticipated that 

stakeholders will have ample 

opportunity to provide comments and 

opinions during the public meeting 

through their participation in breakout 

sessions and in the dialogue and 

question and answer session. 

Table 1 of this document provides 

information on participation in the 

public meeting. 

TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING AND ON SUBMITTING COMMENTS TO THE DOCKET

Dates Electronic addresses Addresses Other information 

Attend public 

meeting.

April 23, 2015, 

from 8:30 a.m. 

to 5:30 p.m., 

and April 24, 

2015, from 

8:30 a.m. to 

12:30 p.m.

Please preregister at http:// 

www.fda.gov/Food/ 

NewsEventsWorkshopsMeetingsConferences/default.htm.

Washington Marriott at Metro 

Center, 775 12th St. NW., 

Washington, DC 20005.

Registration check-in begins at 8 

a.m. 

View Web cast .... April 23, 2015, 

from 8:30 a.m. 

to 5:30 p.m., 

and April 24, 

2015, from 

8:30 a.m. to 

12:30 p.m.

Individuals who wish to participate by Web cast are asked to 

preregister at http:// 

www.fda.gov/Food/ 

NewsEvents/.

WorkshopsMeetingsConferences/ 

default.htm.

...................................................... The Web cast will have closed 

captioning. 

Preregister ........... Register by April 

16, 2015.

Individuals who wish to participate in person are asked to 

preregister at http:// 

www.fda.gov/Food/ 

NewsEvents/.

WorkshopsMeetingsConferences/ 

default.htm.

We encourage the use of electronic registration, if possible.1.There is no registration fee for 

the public meeting. 

Request special 

accommodations due to disability.

Request by April 

8, 2015.

Juanita Yates, email: Juanita.yates@fda.hhs.gov.See FOR FURTHER INFORMATION CONTACT.

mstockstill on DSK4VPTVN1PROD with NOTICES

15614 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING AND ON SUBMITTING COMMENTS TO THE DOCKET— 

Continued 

Dates Electronic addresses Addresses Other information 

Submit electronic 

or written comments.

Submit comments by May 

26, 2015.

Federal eRulemaking Portal: 

http://www.regulations.gov. Follow the instructions for submitting comments.

Mail/Hand delivery/Courier (for 

paper submissions): Division of 

Dockets Management (HFA– 

305), Food and Drug Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852.

Identify your comments with the 

docket number listed in brackets in the heading of this document. We encourage you to 

submit electronic comments by 

using the Federal eRulemaking 

Portal. 

1You may also register via email, mail, or fax. Please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals Ltd., 1210 West McDermott Dr., suite 111, Allen, TX 75013, 704– 

258–4983, FAX: 469–854–6992, email: ctreece@planningprofessionals.com. 

IV. Comments, Transcripts, and 

Recorded Video 

Regardless of attendance at the public 

meeting, interested persons may submit 

to FDA’s Division of Dockets 

Management (see Addresses in table 1 of 

this document) either electronic or 

written comments on FSMA 

implementation issues. You only need 

to send one set of comments. Identify 

the comments with the docket number 

listed in brackets in the heading of this 

document. However, we will not use 

any information or data submitted 

during the public meeting or through 

the docket to inform any FSMA 

rulemakings where the comment 

periods have closed. 

With respect to transcripts, please be 

advised that as soon as a transcript is 

available it will be accessible at http:// 

www.regulations.gov and at FDA’s 

FSMA Web site at http://www.fda.gov/ 

FSMA. You may also view the transcript 

at the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. A transcript 

will also be available in either hardcopy 

or on CD–ROM, after submission of a 

Freedom of Information request. Send 

written requests to the Division of 

Freedom of Information (ELEM–1029), 

12420 Parklawn Dr., Element Bldg., 

Rockville, MD 20857. 

Additionally, we will be video 

recording the public meeting. Once the 

recorded video is available, it will be 

accessible at FDA’s FSMA Web site at 

http://www.fda.gov/FSMA. 

Dated: March 18, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–06656 Filed 3–23–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Interagency Committee on Smoking 

and Health: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Interagency Committee on Smoking and 

Health, Department of Health and 

Human Services, has been renewed for 

a 2-year period through March 20, 2017. 

For information, contact Simon 

McNabb, Designated Federal Officer, 

Interagency Committee on Smoking and 

Health, Centers for Disease Control and 

Prevention, Department of Health and 

Human Services, Patriot’s Plaza, 395 E 

Street SW., M/S P06, Washington, DC 

20201, telephone 202/245–0550 or fax 

202/245–0599, Email: BOL1@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06649 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[60Day–15–15TG; Docket No. CDC–2015– 

0009] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), Centers 

for Disease Control and Prevention 

(CDC). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), as part of its continuing 

efforts to reduce public burden and 

maximize the utility of government 

information, invites the general public 

and other Federal agencies to take this 

opportunity to comment on proposed 

and/or continuing information 

collections, as required by the 

Paperwork Reduction Act of 1995. This 

notice invites comment on Promotion of 

the National Amyotrophic Lateral 

Sclerosis (ALS) Registry to Non-referral 

Centers. 

DATES: Written comments must be 

received on or before May 26, 2015. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2015– 

0009 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulation.gov. Follow the instructions 

for submitting comments. 

• Mail: Leroy A. Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

D74, Atlanta, Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

mstockstill on DSK4VPTVN1PROD with NOTICES